On June 26, 2024, JHM held a media conference at its headquarters in Hangzhou, China. During the event, CEO Ms. Xu Kui and other senior executives shared the latest business developments of the enterprise with journalists. They announced that the recombinant human collagen had successfully completed the industrialization test run, having broken through the 20-ton stable fermentation and purification process.

Following the conference, 30 media outlets—including China Business Network, 21st Century Business Herald, and Jiemian News—provided in-depth coverage of the progress and business achievements.